News for AptarGroup, Inc. (ATR)

\nAptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announces the commencement of

\nAptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has achieved the Platinum level rati

AptarGroup is poised for growth in its Pharma and Closure segments, but challenges are expected in the Beauty segment. See why I rate ATR stock a buy.

AptarGroup shares lag the market and seem overpriced. With new data coming soon, read here to know why waiting to upgrade ATR stock might be the smart move.

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has been named one of Barron's [url=

Summary AptarGroup Inc (ATR), a prominent player in drug and consumer product dosing, dispensing, and protection technologies, has been honored by the global en

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has been recognized for its leadersh

“Boring” stocks, as the name suggests, are not the stocks that grab headlines like fast-growing tech stocks or high-risk investments.

Packaging Corporation of America, Amcor, AptarGroup and Sonoco Products have been highlighted in this Industry Outlook article.

ATR's Q4 top line gains from improved performances of the Pharma and Closures segments.

Explore AptarGroup's (ATR) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Core Sales Growth (Q4): 2%Adjusted Earnings Per Share (Q4): $1.52Adjusted EBITDA Margin (Q4): 23%Pharma Segment Core Sales Growth (Full Year): 8%Pharma Segment

Feb 07, 2025 / 02:00PM GMTOperator Ladies and gentlemen, thank you for standing by. Welcome to Aptar 2024 fourth quarter and annual results conference call. (Op

Earnings Call Insights: AptarGroup, Inc. (NYSE:ATR) Q4 2024Management ViewCEO Stephan Tanda highlighted that Aptar achieved 2% core sales growth in Q4 2024...

AptarGroup, Inc. (NYSE:ATR) Q4 2024 Earnings Conference Call February 7, 2025 9:00 AM ETCompany ParticipantsMary Skafidas - Senior Vice President, Investor...

The following slide deck was published by AptarGroup, Inc.

AptarGroup (ATR) delivered earnings and revenue surprises of 20.63% and 1.10%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong fourth quarter

It's a mixed session on Wall Street, with major indices struggling for direction as investors hold their breath ahead of a key jobs report set for Friday morning. The S&P 500 and the Nasdaq 100 edged up 0.3%, while the Dow Jones slipped 0.1% and small caps held steady.